Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Migraine

  Free Subscription


Articles published in JAMA

Retrieve available abstracts of 12 articles:
HTML format



Single Articles


    August 2022
  1. SLOMSKI A
    Monoclonal Antibody Overcomes Migraine Treatment Failure.
    JAMA. 2022;328:700.
    PubMed    


    March 2022
  2. SLOMSKI A
    Erenumab Safe, Effective for Patients With Migraine With Aura.
    JAMA. 2022;327:804.
    PubMed    


    January 2022
  3. WALTER K
    What Is Migraine?
    JAMA. 2022;327:93.
    PubMed    


    October 2021
  4. HAGAN JC 3RD
    Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults.
    JAMA. 2021;326:1636.
    PubMed    


  5. MOISSET X, Demarquay G, Ducros A
    Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults.
    JAMA. 2021;326:1636-1637.
    PubMed    


  6. WANG Z, VanderPluym JH, Murad MH
    Systematic Review and Meta-analysis of Acute Treatments for Episodic Migraine in Adults-Reply.
    JAMA. 2021;326:1637.
    PubMed    


    August 2021
  7. SLOMSKI A
    Diets High in Omega-3 Fatty Acids Might Ease Migraines.
    JAMA. 2021;326:691.
    PubMed    


    June 2021
  8. BURCH R, Rayhill M
    Acute Treatment for Migraine: Contemporary Treatments and Future Directions.
    JAMA. 2021;325:2346-2347.
    PubMed    


  9. WINNER PK, McAllister P, Chakhava G, Ailani J, et al
    Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
    JAMA. 2021;325:2348-2356.
    PubMed     Abstract available


  10. VANDERPLUYM JH, Halker Singh RB, Urtecho M, Morrow AS, et al
    Acute Treatments for Episodic Migraine in Adults: A Systematic Review and Meta-analysis.
    JAMA. 2021;325:2357-2369.
    PubMed     Abstract available


    May 2021
  11. ROBBINS MS
    Diagnosis and Management of Headache: A Review.
    JAMA. 2021;325:1874-1885.
    PubMed     Abstract available


    February 2021
  12. SLOMSKI A
    Oral Rimegepant Safe, Effective for Migraine Prevention.
    JAMA. 2021;325:713.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: